Concepedia

Author

David Eichenbaum

Retina Vitreous Associates of FloridaORCID

Also Known As

Brian Connolly, Daniel B. Roth, Daniel Roth, David A Eichenbaum, David A. Eichenbaum, David Eichenbaum, Eichenbaum, D.A., Jayanth Sridhar, Patrick Higgins, Pravin U Dugel,

90

Publications

2.1K

Citations

22

H-Index

21

Concepts

All Affiliations

Retina Vitreous Associates of FloridaRetina Consultants of TexasUniversity of South FloridaUniversity of Nevada, RenoSierra Eye Associates
DE

About

David Eichenbaum is an author at Retina Vitreous Associates of Florida specializing in medicine, ophthalmology, and age-related diseases.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

7

940

2

Health Sciences

1

1

27

3

Diabetes

1

1

105

4

Neurology

1

1

27

5

Clinical Epidemiology

1

2

526

David Eichenbaum

×

24

Publications

1.4K

Citations

17

H-Index

YearCitations

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi,

The Lancet

2023

263

Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

Paolo Lanzetta, Jean‐François Korobelnik, Jeffrey S. Heier,

The Lancet

2024

179

TENAYA and LUCERNE

Arshad M. Khanani, Aachal Kotecha, Andrew Chang,

Ophthalmology

2024

124

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

Sunil Patel, David R. Lally, Jason Hsu,

Eye

2023

118

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik,

Ophthalmology

2023

105

Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy

Charles C. Wykoff, David Eichenbaum, Daniel B. Roth,

Ophthalmology Retina

2018

96

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M. Brown, David S. Boyer, V. Diana,

The Lancet

2024

78

Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration

Ana Bety Enríquez, Caroline R. Baumal, Ashley M. Crane,

JAMA Ophthalmology

2021

74

Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)

Rui Wang, Cynthia K. McClard, Stephen Laswell,

BMJ Open Ophthalmology

2022

32

Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study

Sam E. Mansour, Daniel F. Kiernan, Daniel B. Roth,

British Journal of Ophthalmology

2020

28

Page 1